logo

For the Inventor, By the Inventor

Al-Ahsa, Saudi Arabia

Mahesh Attimarad

USPTO Granted Patents = 15 

Average Co-Inventor Count = 11.3

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Hofouf, SA (2022)
  • Al-Ahsa, SA (2023 - 2024)

Company Filing History:

goldMedal15 out of 3,218 
 
King Fahd University of Petroleum and Minerals
 patents

Years Active: 2022-2025

Loading Chart...
15 patents (USPTO):Explore Patents
1. 12297204 - 5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agents (2025-05-13),
2. 12221450 - 5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agents (2025-02-11),
3. 12187733 - 5-(Substitutedphenyl)-7-Imino-7,8-Dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agents (2025-01-07),
4. 11974991 - Adenosine receptor activity of methyl/ethyl 3-(substituted benzoyl)-6,8-dimethylindolizine-2-substituted-1-carboxylates (2024-05-07),
5. 11964982 - 5-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agents (2024-04-23),
6. 11938120 - Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents (2024-03-26),
7. 11932649 - 5-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agents (2024-03-19),
8. 11926627 - Substituted 7-methyl quinoline derivatives as antitubercular agents (2024-03-12),
9. 11919900 - 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents (2024-03-05),
10. 11884677 - 5-(substitutedphenyl)-7-imino-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agents (2024-01-30),
11. 11884631 - Substituted phenyl quinolin-l-ium bromide derivative as anti-tubercular agents (2024-01-30),
12. 11845746 - Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents (2023-12-19),
13. 11807640 - 7-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as anti-tubercular agents (2023-11-07),
14. 11807553 - Decontamination of water using guar gum derivatives and applications thereof (2023-11-07),
15. 11530217 - Antitubercular compounds (2022-12-20),

Title: Mahesh Attimarad: A Pioneer in Antibacterial Innovations

Introduction

Mahesh Attimarad, an accomplished inventor based in Al-Ahsa, Saudi Arabia, has made significant contributions to the field of antibacterial agents. With a portfolio of 15 patents, his research aims to address microbial and bacterial infections through innovative compounds.

Latest Patents

Among his latest patents are the 5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues, which serve as promising antibacterial agents. These compounds are designed for treating microbial and bacterial infections and are focused on the specific structures of formula 4. Such innovations position him at the forefront of antibiotic research and development.

Career Highlights

Mahesh Attimarad currently works at King Fahd University of Petroleum and Minerals, where his research is concentrated on developing advanced compounds that fight bacterial infections. His extensive experience and academic background underpin his innovative work, contributing greatly to both theoretical and practical advancements in the field.

Collaborations

Throughout his career, Mahesh has collaborated with notable colleagues such as Katharigatta N Venugopala and Anroop B Nair. These collaborations reflect a commitment to teamwork and innovation, enhancing the research findings that aim to revolutionize treatment modalities for infections.

Conclusion

In summary, Mahesh Attimarad's work exemplifies dedication to innovation in the medical field, particularly in developing new antibacterial agents. His achievements, backed by a strong patent portfolio and collaborative efforts, are a testament to his influence as an inventor in combating microbial challenges. Through his ongoing research, the potential for significant advancements in antibacterial treatments continues to grow.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…